主页文献库搜索
[Application of polygenic risk score-based comprehensive breast cancer risk a...

Ye(Y),Hu(X),Yan(K),Yu(J),Chen(Y),Zou(Y),Lu... Zhejiang Da Xue Xue Bao Yi ... 2026-05-25

A patient, whose family carried a BRCA1: c.5154G>A pathogenic variant, had experienced infertility for three years and s...

Rare BRCA1 c.3418_3419insTGACTACT:p.S1140Mfs*18 germline mutation in a family...

Zhai(C),Jia(L),Wang(C),Chen(L),Han(T),Xiao(D) Oncol Lett 2026-07-00

BRCA1 is among one of the most frequently mutated tumor suppressor genes in breast and ovarian cancer. In the present re...

Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patie...

Crawford(TB),Tayeb(M),Barrett(E),Al-Saleem... J Natl Compr Canc Netw 2026-06-02

...BRCA1 PGVs were similar (1.9% vs 1.3%; Padjusted=.0885 and 0.6% vs 0.5%; Padjusted=.8005, respectively). PGV rates did n...

Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early tr...

Tavares(MC),Balint(FC),Barroso-Sousa(R),Te... NPJ Breast Cancer 2026-06-02

...BRCA1/2 variants remains limited. We analyzed 726 consecutively treated patients from the multicenter Neo-Real/GBECAM-01...

Spatial, temporal, and molecular heterogeneity of ADC targets in high-grade s...

Li(X),Janik(T),Möbs(M),Florian(S),Schmitt(... Br J Cancer 2026-09-00

...BRCA1/2-mutated tumours. Folate receptor-alpha (FolR1) showed notable spatial heterogeneity: 20.2% switched therapeutic-...

Ferroptosis and chemotherapy resistance in ovarian cancer: molecular mechanis...

Li(S),Yang(L),Zhu(Z) J Ovarian Res 2026-06-02

...BRCA1-dependent ubiquitination of GPX4 and its implications for PARP inhibitor synthetic lethality, NR1D2-mediated trans...

The PER2:BRCA1:POU2F1(OCT-1) ternary complex represents a multi-component sca...

Kadukhina(E),Jia(S),Villa(LM),Yi(X),Capell... Neurobiol Sleep Circadian R... 2026-05-00

...BRCA1 as a novel PER2-interacting protein. Biochemical mapping revealed that PER2 engages BRCA1 through multiple discret...

The Performance of In Silico Prediction Tools for Variant Curation in a Panel...

Nelson(N),Niaz(A),Fairfax(K),Bryan(TM),Luc... Hum Mutat None

...BRCA1, BRCA2, TP53, TERT and ATM), when recommended thresholds were used, in silico tool predictions showed inferior sen...

Adjuvant chemotherapy combined with pembrolizumab immunotherapy for primary t...

Shen(X),Yang(J),Du(Y),Fu(D) Front Immunol None

...BRCA1/2 mutation. The patient underwent curative mastectomy with sentinel lymph node biopsy (pT2N0M0, stage IIA). Adjuva...

Elevated ESR2 and BRCA1 gene expression in adenomyosis associated with endome...

La Torre(F),Nardi(E),Bonechi(F),Vannuccini... Gynecol Endocrinol 2026-12-31

...BRCA1) and progesterone (PGR plus FOXO1, and CYP26A1) receptor pathway-related genes in hysterectomy specimens of patien...

上一页 28 29 30 31 32 33 34 35 36 下一页 32 / 共 1000

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com